SCHEMBL13033028

SCHEMBL13033028

CCCCC/C=C\CCCC/C=C\C/C=C\CCCC(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 7/20 1.00
PPARD Q03181 6/20 1.00
PPARA Q07869 6/20 1.00
ALDH1A1 P00352 5/20 1.00
FABP4 P15090 4/20 1.00
HSD17B10 Q99714 4/20 1.00
LMNA P02545 3/20 1.00
CYP19A1 P11511 3/20 1.00
ALOX15 P16050 3/20 1.00
NR4A2 P43354 3/20 1.00
MAPT P10636 3/20 1.00
BLM P54132 3/20 1.00
L3MBTL1 Q9Y468 2/20 1.00
KDM4E B2RXH2 2/20 1.00
CYP3A4 P08684 2/20 1.00
HPGD P15428 2/20 1.00
TDP1 Q9NUW8 2/20 1.00
AKR1C3 P42330 2/20 1.00
USP2 O75604 2/20 1.00
RECQL P46063 2/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7875988 1.00 PPARG (1.00) PPARGPPARDPPARAALDH1A1FABP4
Arachidonic Acid SCHEMBL18185463 1.00 PPARG (1.00) PPARGPPARDPPARAALDH1A1FABP4
SCHEMBL7875990 1.00 PPARG (1.00) PPARGPPARDPPARAALDH1A1FABP4
SCHEMBL17540736 1.00 PPARG (1.00) PPARGPPARDPPARAALDH1A1FABP4
SCHEMBL542242 1.00 PPARG (1.00) PPARGPPARDPPARAALDH1A1FABP4
Arachidonic Acid SCHEMBL25417373 1.00 PPARG (1.00) PPARGPPARDPPARAALDH1A1FABP4
Arachidonic Acid SCHEMBL18185503 1.00 PPARG (1.00) PPARGPPARDPPARAALDH1A1FABP4
Arachidonic Acid SCHEMBL607755 1.00 PPARG (1.00) PPARGPPARDPPARAALDH1A1FABP4
Arachidonic Acid SCHEMBL20656587 1.00 PPARG (1.00) PPARGPPARDPPARAALDH1A1FABP4
Arachidonic Acid SCHEMBL3064936 1.00 PPARG (1.00) PPARGPPARDPPARAALDH1A1FABP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017167415-A1 COMPOSITIONS COMPRISING FATTY ACIDS AND THEIR USE NESTEC S.A. (CH) 2017-10-05 WO disclosed
US-9616017-B2 Two part formulation system for ophthalmic delivery ALLERGAN, INC. (US) 2017-04-11 US disclosed
US-20100317733-A1 USE OF CIS-EPOXYEICOSANTRIENOIC ACIDS AND INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE TO REDUCE PULMONARY INFILTRATION BY NEUTROPHILS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-12-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100317733-A1 USE OF CIS-EPOXYEICOSANTRIENOIC ACIDS AND INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE TO REDUCE PULMONARY INFILTRATION BY NEUTROPHILS EPHX1, EPHX2, LTA4H PPARG 396/4885PPARD 697/4885PPARA 695/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.